Printer-friendly version Send to friend
  • Increase
  • Decrease
  • Normal

Current Size: 100%

Pressreleases

Sep 2, 2010
Redemption of warrants
Redemption of warrants on 31st August 2010 has led to an increase in BioGaia´s share capital with SEK 60,400, which on 2 September amounts to SEK 17,270,962. The number of shares has increased with 60,400 class B-shares through which the number of class B-shares now amounts to 16,530,294 with no change in the number of class A-shares, i.e. 740,668. The total number of shares is thereby equivalent to 23,936,974 votes.  
Read more
Aug 17, 2010
BioGaia AB Interim report 1 January - 30 June 2010
Interim period, 1 January - 30 June 2010    Net sales amounted to SEK 124.4 million (112.4), an increase of SEK 12.0 million (11%). Excluding foreign exchange effects and early deliveries in the previous year, the increase in net sales was 27%*.Operating profit was SEK 31.5 million (29.9), an improvement of SEK 1.6 million (5 %).
Read more
Jul 22, 2010
New study published: Lactobacillus reuteri Protectis effective in infants with chronic constipation
Constipated infants supplemented with L. reuteri Protectis had a significantly higher frequency of bowel movements compared to the placebo group. Stool consistency improved significantly in the L. reuteri Protectis group, although no significant difference was seen compared to placebo. - This is the first study to show that L.
Read more
Jun 10, 2010
New study presented on Lactobacillus reuteri Protectis
Lactobacillus reuteri Protectis reduced crying time in infants with colic After only one week of supplementation the reduction in daily crying time was 74 % among the infants supplemented by L. reuteri Protectis compared to 38 % in the placebo group. At the end of the study there was a significant difference between the two groups. - These results are in line with previous studies on colics and confirm the benefit of L.
Read more
Jun 3, 2010
BioGaia signs agreement for China
The agreement gives the pharmaceutical biotechnology company Asia United (China) Medical Co. Limited the exclusive rights to sell BioGaia's probiotic drops in Mainland China. - This is a firm first step into the Chinese market for our branded supplement products, says Peter Rothschild, President, BioGaia AB. Launch of the product is estimated at the end of 2011 following relevant local registration which will be taken care of by Asia United. The products will be sold under the BioGaia brand.
Read more
May 26, 2010
Change in number of shares in BioGaia AB
Redemption of warrants during May has led to an increase of BioGaia's share capital by SEK 3,000 to a total of SEK 17,210,562. The number of shares has increased by 3,000 B shares to a total of 740,668 A shares and 16,469,894 B shares which is equal to 23,876,574 votes.  
Read more
May 10, 2010
New study published: Lactobacillus reuteri Protectis reduced gastrointestinal symptoms and hospital stay in premature newborns
Lactobacillus reuteri Protectis reduced gastrointestinal symptoms and hospital stay in premature newborns The study showed that infants supplemented with L. reuteri Protectis had a significantly reduced number of gastrointestinal symptoms compared to those supplemented with L. rhamnosus (LGG) and controls. Also duration of hospital stay was significantly reduced by L. reuteri Protectis.
Read more
May 7, 2010
Annual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB on 6 May 2010 voted to approve the following resolutions: - a dividend of SEK 1.50 per share - re-election of Board members Jan Annwall, Stefan Elving, Thomas Flinck, David Dangoor, Inger Holmström, Jörgen Thorball and Paula Zeilon - re-election of David Dangoor as Board Chairman - Election of Grant Thornton Sweden AB, which has announced its intention to appoint Authorized Public Accountant Lena Möllerström Nording as Auditor in Chief.
Read more